Sean Moran

(Mr. Sean Moran CPA)

Currently holds a position at Corbus Pharmaceuticals Holdings Inc

Positions

Position Company Period
Chief Financial Officer Corbus Pharmaceuticals Holdings Inc None -
Acting Chief Financial Officer InVivo Therapeutics Holdings Corp Aug. 22, 2013 - Sept. 9, 2013
Sean Moran's trades of Corbus Pharmaceuticals Holdings Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2025-02-18 2025-02-14 PS Planned sale
2,792 -3.7%
8.76
USD 24,446
2,792 -3.7% 8.76 USD 24,446
2024-06-18 2024-06-18 PS Planned sale
1,958 -3.9%
42.12
USD 82,479
1,958 -3.9% 42.12 USD 82,479
2024-06-18 2024-06-17 PS Planned sale
6,730 -12.2%
46.77
USD 314,789
6,730 -12.2% 46.77 USD 314,789
2024-06-18 2024-06-14 PS Planned sale
7,788 -13.8%
49.87
USD 388,417
7,788 -13.8% 49.87 USD 388,417
2024-06-18 2024-06-14 PS Planned sale
1,567 -3.1%
49.87
USD 78,152
1,567 -3.1% 49.87 USD 78,152
2022-08-10 2022-08-10 B Purchase
20,000 +11.2%
0.26
USD 5,198
20,000 +11.2% 0.26 USD 5,198
2022-05-16 2022-05-16 B Purchase
12,000 +7.2%
0.30
USD 3,600
12,000 +7.2% 0.30 USD 3,600
2022-03-10 2022-03-10 B Purchase
15,000 +9.9%
0.37
USD 5,550
15,000 +9.9% 0.37 USD 5,550
2020-12-22 2020-12-21 PS Planned sale
87,500 -20.0%
1.75
USD 153,125
87,500 -20.0% 1.75 USD 153,125
2020-12-22 2020-12-18 PS Planned sale
53,610 -13.3%
1.40
USD 75,054
53,610 -13.3% 1.40 USD 75,054
2020-12-18 2020-12-16 PS Planned sale
36,923 -9.6%
1.32
USD 48,628
36,923 -9.6% 1.32 USD 48,628
2019-05-14 2019-05-14 B Purchase
100 +0.0%
7.12
USD 712
100 +0.0% 7.12 USD 712
2019-03-14 2019-03-14 B Purchase
1,500 +0.4%
6.67
USD 10,005
1,500 +0.4% 6.67 USD 10,005
2013-09-04 2013-09-03 B Purchase
20,000 +50.0%
1.02
USD 20,400
20,000 +50.0% 1.02 USD 20,400
// ... existing code ... // ... rest of the file ...